Eli Lilly and Company (LLY) announced the successful completion of its acquisition of Morphic Holding (MORF). Morphic’s common stock will be delisted from The Nasdaq Global Market.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- Lilly Completes Acquisition of Morphic to Improve Outcomes and Expand Options for People Living with Inflammatory Bowel Disease
- Biden administration announces lower prices for 10 Medicare drugs in 2026
- Roche passed on weight-loss pilll now being developed by Eli Lilly, FT says
- U.S. to announce prices for drugs in Medicare negotiations, NY Times says
- LLY, NVO: Which GLP-1 Stock Is the Better Bet?